Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS

Gareth Gregory; Michael J Dickinson; Costas Yannakou; Jonathan Wong; Piers A. Blombery; Greg Corboy; Lev Kats; Timothy Crozier; Beena Kumar; Miles Prince; Stephen S Opat; Jake Shortt

doi:10.1097/HS9.0000000000000187

Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS

Gareth Gregory, Michael J Dickinson, Costas Yannakou, Jonathan Wong, Piers A. Blombery, Greg Corboy, Lev Kats, Timothy Crozier, Beena Kumar, Miles Prince, Stephen S Opat, Jake Shortt

Research output: Contribution to journal › Article › Other › peer-review

15 Citations (Scopus)

Original language	English
Article number	e187
Number of pages	4
Journal	HemaSphere
Volume	3
Issue number	2
DOIs	https://doi.org/10.1097/HS9.0000000000000187
Publication status	Published - Apr 2019

Keywords

T cell
Azacitidine
angioimmunoblastic
TET2
Refractory
Lymphoma
Remission

Access to Document

10.1097/HS9.0000000000000187

Cite this

Gregory, G., Dickinson, M. J., Yannakou, C., Wong, J., Blombery, P. A., Corboy, G., Kats, L., Crozier, T., Kumar, B., Prince, M., Opat, S. S., & Shortt, J. (2019). Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS. HemaSphere, 3(2), Article e187. https://doi.org/10.1097/HS9.0000000000000187

@article{d52ff8106e114464a1e09e7ad1361a8b,

title = "Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS",

keywords = "T cell, Azacitidine, angioimmunoblastic, TET2, Refractory, Lymphoma, Remission",

author = "Gareth Gregory and Dickinson, {Michael J} and Costas Yannakou and Jonathan Wong and Blombery, {Piers A.} and Greg Corboy and Lev Kats and Timothy Crozier and Beena Kumar and Miles Prince and Opat, {Stephen S} and Jake Shortt",

year = "2019",

month = apr,

doi = "10.1097/HS9.0000000000000187",

language = "English",

volume = "3",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS

AU - Gregory, Gareth

AU - Dickinson, Michael J

AU - Yannakou, Costas

AU - Wong, Jonathan

AU - Blombery, Piers A.

AU - Corboy, Greg

AU - Kats, Lev

AU - Crozier, Timothy

AU - Kumar, Beena

AU - Prince, Miles

AU - Opat, Stephen S

AU - Shortt, Jake

PY - 2019/4

Y1 - 2019/4

KW - T cell

KW - Azacitidine

KW - angioimmunoblastic

KW - TET2

KW - Refractory

KW - Lymphoma

KW - Remission

UR - http://www.scopus.com/inward/record.url?scp=85080851206&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000187

DO - 10.1097/HS9.0000000000000187

M3 - Article

AN - SCOPUS:85080851206

SN - 2572-9241

VL - 3

JO - HemaSphere

JF - HemaSphere

IS - 2

M1 - e187

ER -

Rapid and durable complete remission of refractory AITL with azacitidine treatment in absence of TET2 mutation or concurrent MDS

Keywords

Access to Document

Other files and links

Cite this